Urinary Tract Infection Testing Market Size, Share, Trends And Outlook Report 2025-2033

Urinary Tract Infection Testing Market Overview:

The urinary tract infection (UTI) testing market is growing steadily due to the rising prevalence of UTIs, especially among women, the elderly, and patients with chronic conditions. Increasing awareness about early diagnosis, coupled with advancements in rapid diagnostic methods, is driving market demand. The shift from traditional culture tests to point-of-care testing (POCT) and molecular diagnostics is further boosting adoption. Additionally, growing healthcare expenditure, improved access to diagnostic facilities, and technological innovations in urine analysis are supporting market expansion worldwide.

The global urinary tract infection testing market size was valued at USD 622.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 877.0 Million by 2033, exhibiting a CAGR of 3.89% during 2025-2033. North America currently dominates the market, holding a significant market share of over 35.0% in 2024. The urinary tract infection testing market share is primarily driven by the rising prevalence of urinary tract infections among women, increasing awareness about the benefits of timely diagnosis, and improvements in healthcare infrastructure.

Request for a sample copy of this report: https://www.imarcgroup.com/urinary-tract-infection-testing-market/requestsample

Key Highlight:

• Rising Disease Burden: Increasing UTI incidence rates globally.
• Technological Advances: Adoption of molecular diagnostics, POCT, and automated urine analyzers.
• Healthcare Initiatives: Government programs supporting early diagnosis and infection management.
• Market Growth Drivers: Expanding geriatric population and rising antibiotic resistance concerns.
• Regional Insights: North America and Europe lead, while Asia-Pacific is emerging as a high-growth region.

Key Trends:

• Growing preference for rapid, accurate, and non-invasive diagnostic tests.
• Increasing adoption of AI-powered diagnostic tools for faster result interpretation.
• Rising trend toward home-based and telehealth-supported urine testing kits.
• Strong focus on antimicrobial stewardship due to rising antibiotic resistance.
• Collaborations between diagnostic companies and healthcare providers to expand access.

Industry Trends and Drivers:

Rising Prevalence of Urinary Tract Infections (UTIs): The increasing incidence of UTIs globally is one of the major factors boosting the market growth. Moreover, the rising geriatric population who are susceptible to these infections, especially post-menopausal women, and individuals with underlying health conditions, such as diabetes or kidney disorders, is favoring the market growth. Besides this, the rising infection rate leading to a growing demand for accurate and timely diagnostic tests, which are essential in reducing the duration of infections and preventing complications like kidney damage is contributing to the market growth. Besides this, the heightened reliance of healthcare providers on urine culture, dipstick tests, and advanced molecular diagnostic techniques to detect infections early and prescribe effective treatments is fostering the market growth.

Rapid Advancements in Diagnostic Technologies: The rising technological advancements in diagnostic testing, such as the development of newer molecular and point-of-care (POC) diagnostic technologies, are catalyzing the market growth. These advancements allow for faster, more accurate results, minimizing the delay between testing and treatment. Moreover, the rise of nucleic acid amplification tests (NAATs), which detect bacterial deoxyribonucleic acid (DNA) in urine samples to improve diagnostic accuracy, is contributing to the market growth. Additionally, the burgeoning integration of artificial intelligence (AI) and machine learning (ML) in diagnostics to enhance the interpretation of test results, offering personalized insights into the infection's severity and guiding treatment options, is creating a positive outlook for the market.

Increasing Demand for Home-Based and Point-of-Care (POC) Testing: The growing preference for home-based and point-of-care testing is fostering the market growth. Moreover, the increasing emphasis on patient convenience and the rising demand for self-monitoring healthcare tools, promoting many individuals to opt for home UTI test kits that provide quick and reliable results, is enhancing the market growth. These kits use dipsticks or rapid test strips, which can detect the presence of nitrites or leukocytes in the urine, indicating a potential infection. Additionally, the development of point-of-care tests in clinics, pharmacies, or retail settings that offer patients a convenient alternative to traditional lab testing, with results available within minutes, is favoring the market growth.

Urinary Tract Infection Testing Market Report Segmentation:
Breakup By Test Type:

• Urinalysis
• Urine Cultures
• Susceptibility Testing

Urinalysis account for the majority of shares due to its efficiency in detecting infections through simple chemical and microscopic analysis of urine samples.

Breakup By Infection Type:

• Urethritis
• Cystitis
• Pyelonephritis

Cystitis dominates the market as it is an infection of the bladder that is a most frequently diagnosed urinary tract infection in women.

Breakup By Test Kit:

• Home Test Kits
• Laboratory Test Kits

Laboratory test kits represents the majority of shares due to their high accuracy and widespread use in hospitals and diagnostic labs.

Breakup By End User:

• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Others

Hospitals hold the majority of shares as they perform the majority of UTI diagnostic tests, given their access to advanced testing facilities and the need for precise diagnoses in acute cases.

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America holds the leading position owing to a large market for urinary tract infection testing driven by its advanced healthcare infrastructure, high awareness of UTIs, and access to cutting-edge diagnostic technologies.

Top Urinary Tract Infection Testing Market Leaders:

The urinary tract infection testing market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies.

Some of the key players in the market are:

• ACON Laboratories Inc.
• Arkray Inc.
• Cardinal Health Inc.
• F. Hoffmann-La Roche Ltd.
• Randox Laboratories Ltd.
• Siemens Healthcare Private Limited (Siemens AG)
• Sysmex Corporation
• Thermo Fisher Scientific Inc.

Ask An Analyst: https://www.imarcgroup.com/request?type=report&id=12645&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-201971-6302

This release was published on openPR.